Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Q4 Revs Climb 13 Percent on ‘Robust’ Sales Across the Board

NEW YORK (GenomeWeb News) —Sigma-Aldrich today said fourth-quarter revenue rose 13 percent as R&D spending increased 9 percent and net income widened 25 percent.
 
Total receipts for the three months ended Dec. 31, 2006, rose to $464.5 million from $410.5 million year over year.
 
The jump in receipts was fueled by “robust” sales in all of the company’s major units, CEO Jai Nagarkatti said, adding that the better-than-predicted growth gives the company “confidence that our strategic initiatives are gaining momentum.”
 
Revenue from Sigma’s Research Essentials division increased to $88 million from 81.3 million; Research Specialties receipts jumped to $172.6 million from $152.6 million; and Research Biotech revenue increased to $70.6 million from $64.8 million.
 
R&D spending increased to $13.3 million from $12.2 million year over year.
 
The company said profit increased to $71.6 million $57.3 million in the year-ago period.
 
Sigma-Aldrich said it had around $173.8 million in cash and equivalents as of Dec. 31, 2006.
 
The company said it expects 2007 revenues to increase roughly 7 percent year over year. Broken down, growth in Research Biotech may slip somewhat from the company’s earlier predictions from around 10 percent to between 7 and 9 percent.
 
Sigma said organic growth in its other units should meet or exceed the goals of 4 percent for Research Essentials, 6 percent for Research Specialties, and 10 percent for its SAFC segment.
 
The company expects “modest” growth from its recent acquisitions, with Epichem expected to make the largest contribution by adding 2 percent to revenues. 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.